Cargando…
Vaccine Candidates for the Control and Prevention of the Sexually Transmitted Disease Gonorrhea
The World Health Organization (WHO) has placed N. gonorrhoeae on the global priority list of antimicrobial resistant pathogens and is urgently seeking the development of new intervention strategies. N. gonorrhoeae causes 86.9 million cases globally per annum. The effects of gonococcal disease are se...
Autores principales: | Haese, Ethan C., Thai, Van C., Kahler, Charlene M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310131/ https://www.ncbi.nlm.nih.gov/pubmed/34358218 http://dx.doi.org/10.3390/vaccines9070804 |
Ejemplares similares
-
Potential Applications of Microparticulate-Based Bacterial Outer Membrane Vesicles (OMVs) Vaccine Platform for Sexually Transmitted Diseases (STDs): Gonorrhea, Chlamydia, and Syphilis
por: Chbib, Christiane, et al.
Publicado: (2021) -
Vaccines against sexually transmitted diseases
por: Corbeil, Lynette B, et al.
Publicado: (2003) -
Development and comparison of predictive models for sexually transmitted diseases—AIDS, gonorrhea, and syphilis in China, 2011–2021
por: Zhu, Zhixin, et al.
Publicado: (2022) -
Trends in the Epidemiology of Sexually Transmitted Disease, Acquired Immune Deficiency Syndrome (AIDS), Gonorrhea, and Syphilis, in the 31 Provinces of Mainland China
por: Ye, Xuechen, et al.
Publicado: (2019) -
Oropharyngeal Gonorrhea in Absence of Urogenital Gonorrhea in Sexual Network of Male and Female Participants, Australia, 2018
por: Cornelisse, Vincent J., et al.
Publicado: (2019)